Secant Group officials think they’ve cracked vascular regeneration: Here’s how

Secant Group today announced what it described as game-changing technology to advance vascular regeneration, solving problems that surgeons presently have when it comes to vascular harvesting and the non-resorbable synthetic graft compliance mismatching. The technology, which Secant (Telford, Pa.) developed in partnership with its sister company SanaVita Medical, involves a synthetic, small bore, vessel with a

CES 2018: Medical technologies you need to know

Updated Jan. 16, 2018 Mobile health devices and wearables have increasingly played a prominent role at the annual CES show in Las Vegas. Health and medical devices touted at CES 2018 sought to improve everything from heart health to posture. Here are 13 companies that exhibited digital health solutions at this year’s show. Next >>

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

How startup Nanowear partnered with Secant: It took a year and a lot of meetings

Nanowear, which creates cloth-based diagnostic monitoring nanosensor technology, has entered into an exclusive, worldwide supply-chain partnership agreement with The Secant Group for scaled manufacturing and production of its medical-grade cloth-based nanosensor technology. Under the agreement, Nanowear and The Secant Group will have the collective obligation for marketing the technology and associated products. Nanowear received FDA 510(k) clearance for its remote congestive heart

Bringing medical device manufacturing back to the U.S.: Here’s how it’s done

Here’s an inside look at one organization’s decision to bring medical device manufacturing back onshore. John Thomas, Bonifacio Consulting Services Deciding where and how to manufacture a product is without a doubt one of the most important decisions a medical device OEM faces. This decision has many implications, from the overall successful manufacture of the product

Medical device companies: These 15 performed the best in 2017

Updated Jan. 5, 2018 Among the most successful medical device companies of 2017, there were two themes: innovation and breadth of services. That was the major takeaway of an MDO analysis of the stock performance of the 100 largest publicly traded medtech companies in the world. What does innovation mean? Think Align Technology (Nasdaq:ALGN) and

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Stroke treatment: There’s a simple way to improve it in the U.S.

Technology is already available to greatly improve outcomes for people suffering from strokes, but the present healthcare system is standing in the way of people getting it, according to Stacey Pugh, VP and general manager of the neurovascular unit at Medtronic. The most important thing that could boost stroke treatment is passing proper legislation about

Medtech stories we missed this week: Dec. 29, 2017

From NanoVibronix’s new Indian regulatory and distribution agreement to Guided Therapeutics’s Turkish distribution deal, here are five medtech stories we missed this week but thought were still worth mentioning. 1. NanoVibronix inks deal with Indian regulatory and distribution consultant NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory

How blocking an immune system response could improve heart attack survival

California researchers have discovered that the immune system’s response after a heart attack plays a significant role in what happens following a heart attack. Following a heart attack, heart cells begin to die, causing the immune system to send immune cells into the dead tissue to clear debris and start stabilizing the heart wall. University

These artificial heart muscle patches can repair dead heart muscles

A team of biomedical engineers have developed a fully functioning artificial human heart muscle that can be used as a patch to repair dead heart muscle. Duke University biomedical engineers developed the patch to be used in human patients who have previously suffered a heart attack. “Right now, virtually all existing therapies are aimed at

Medtech stories we missed this week: Dec. 8, 2017

From Minimus Spine’s European distribution deal to Stimwave receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Minimus Spine inks EU distribution deal Minimus Spine announced in a Dec. 4 press releasethat it has signed its first European distribution deal with Italian company Moss and

How BioSig is using plug and play as a medtech startup strategy

Startups, as a rule, should have a plan for their technology to grow. But it is rare that a medical technology startup aims to be plug and play, fitting into many therapeutic areas from cardio to Alzheimer’s to diabetes. BioSig’s Pure EP, an electrophysiology signal recording and processing system, could potentially provide valuable insight during

Medicare finalizes cuts to value-based healthcare programs

The Centers for Medicare & Medicaid Services yesterday finalized cuts to a trio of bundled payment pilot programs aimed at lowering healthcare costs and improving outcomes. The federal health insurer cut the Comprehensive Care for Joint Replacement Model, or CJR, effectively in half, from 67 geographic areas participating to 34, meaning about 470 hospital participants instead of 800. […]

FDA clears AliveCor’s KardiaBand ECG for Apple Watch

AliveCor said today that the FDA cleared its KardioBand electrocardiogram device for the Apple Watch, designed to monitor for early signs of atrial fibrillation. First introduced in March 2016, KardiaBand is the first medical device accessory to be cleared by the federal safety watchdog for the Apple Watch, Mountain View, Calif.-based AliveCor said. It’s designed to display […]

These 10 medtech companies care a lot about research

Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in

Pages: 1 2 3 4 5 6 7 8 9 10 11

Artificial organ market worth expected to double in the next 5 years

The artificial organ market is expected to more than double by 2022, according to a market analysis report from Yole Développement in France. The market is expected to be work $1.3B in 2017 and with a consumer annual growth rate (CAGR) of 20%, it is expected to be work $3.5B by 2022. “This impressive growth